This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): AM 0015, AM-0015, Recombinant human Interleukin-15, IL-15
AM0015 is recombinant human Interleukin-15. AM0015 is being developed by ARMO for use in combination with AM0010. IL-15 is an activator of the innate and adaptive immune system and induces anti-tumor responses in animal models via: activation and proliferation of NK cells, antibody dependent cytotoxicity (ADCC), broad activation of the T cell repertoire, and providing survival signal to memory T cells.
Pink Sheet Chart: FDA Recalls -- Oct. 6, 2010
Additional information available to subscribers only: